NasdaqGS - Nasdaq Real Time Price USD
Omnicell, Inc. (OMCL)
At close: November 18 at 4:00 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 7 | 8 | 9 |
| Avg. Estimate | 0.58 | 0.31 | 1.68 | 1.8 |
| Low Estimate | 0.55 | 0.21 | 1.65 | 1.51 |
| High Estimate | 0.61 | 0.42 | 1.72 | 2.06 |
| Year Ago EPS | 0.33 | 0.03 | 1.91 | 1.68 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 7 | 8 |
| Avg. Estimate | 297.89M | 270.83M | 1.1B | 1.16B |
| Low Estimate | 286M | 250.9M | 1.1B | 1.12B |
| High Estimate | 301.05M | 287.63M | 1.11B | 1.22B |
| Year Ago Sales | 258.85M | 246.15M | 1.15B | 1.1B |
| Sales Growth (year/est) | 15.08% | 10.03% | -3.68% | 4.78% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.15 | -0.09 | 0.14 | 0.42 |
| EPS Actual | 0.33 | 0.03 | 0.51 | 0.56 |
| Difference | 0.18 | 0.12 | 0.37 | 0.14 |
| Surprise % | 114.45% | 132.03% | 253.45% | 33.61% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.58 | 0.31 | 1.68 | 1.8 |
| 7 Days Ago | 0.58 | 0.23 | 1.68 | 1.8 |
| 30 Days Ago | 0.47 | 0.25 | 1.42 | 1.57 |
| 60 Days Ago | 0.47 | 0.25 | 1.42 | 1.57 |
| 90 Days Ago | 0.47 | 0.27 | 1.41 | 1.54 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 6 | 6 | 6 | 6 |
| Up Last 30 Days | 6 | 6 | 6 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OMCL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 74.96% | -- | -- | 5.00% |
| Next Qtr. | 940.00% | -- | -- | 12.00% |
| Current Year | -12.04% | -- | -- | 2.10% |
| Next Year | 7.38% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 10/31/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 10/31/2024 |
| Downgrade | B of A Securities: Buy to Neutral | 10/31/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 10/14/2024 |
| Reiterates | Benchmark: Buy to Buy | 10/9/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 8/23/2024 |
Related Tickers
PRVA Privia Health Group, Inc.
20.95
-1.18%
PINC Premier, Inc.
22.39
-0.40%
RCM R1 RCM Inc.
14.31
+0.07%
WEAV Weave Communications, Inc.
13.07
-1.51%
PHR Phreesia, Inc.
18.81
+4.27%
BTSG BrightSpring Health Services, Inc.
18.68
-4.84%
TBRG TruBridge, Inc.
16.08
+1.71%
HCAT Health Catalyst, Inc.
7.53
-1.57%
HSTM HealthStream, Inc.
31.31
-0.25%
NRC National Research Corporation
18.47
-3.50%